Skip to main content

Venture

Inside Servier’s new €200M venture fund

Thursday, April 30, 2026 · first reported by European Biotechnology Magazine

Servier launches €200M venture fund (approx. $220M) targeting pharma/biotech innovation; expands corporate venture program.

Size
$220M
Stage
Launch
Asset class
Venture
Geography
Europe

The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.

Coverage

1 source

More in Venture capital

From the same day